163 related articles for article (PubMed ID: 35202116)
21. Binding of nucleotide triphosphates to cardiotoxin analogue II from the Taiwan cobra venom (Naja naja atra). Elucidation of the structural interactions in the dATP-cardiotoxin analogue ii complex.
Jayaraman G; Krishnaswamy T; Kumar S; Yu C
J Biol Chem; 1999 Jun; 274(25):17869-75. PubMed ID: 10364232
[TBL] [Abstract][Full Text] [Related]
22. Elucidating the Venom Diversity in Sri Lankan Spectacled Cobra (
Wong KY; Tan KY; Tan NH; Gnanathasan CA; Tan CH
Toxins (Basel); 2021 Aug; 13(8):. PubMed ID: 34437429
[TBL] [Abstract][Full Text] [Related]
23. The In Vitro Study of Anti-leishmanial Effect of Naja naja oxiana Snake Venom on Leishmania major.
Fallahi N; Shahbazzadeh D; Maleki F; Aghdasi M; Tabatabaie F; Khanaliha K
Infect Disord Drug Targets; 2020; 20(6):913-919. PubMed ID: 31903885
[TBL] [Abstract][Full Text] [Related]
24. Putative membrane lytic sites of P-type and S-type cardiotoxins from snake venoms as probed by all-atom molecular dynamics simulations.
Gorai B; Karthikeyan M; Sivaraman T
J Mol Model; 2016 Oct; 22(10):238. PubMed ID: 27628673
[TBL] [Abstract][Full Text] [Related]
25. Molecular Mechanism by which Cobra Venom Cardiotoxins Interact with the Outer Mitochondrial Membrane.
Li F; Shrivastava IH; Hanlon P; Dagda RK; Gasanoff ES
Toxins (Basel); 2020 Jun; 12(7):. PubMed ID: 32605112
[TBL] [Abstract][Full Text] [Related]
26. Action mechanism of cobra venom, cardiotoxin and allied substances on muscle contraction.
SARKAR NK
Proc Soc Exp Biol Med; 1951 Nov; 78(2):469-71. PubMed ID: 14911918
[No Abstract] [Full Text] [Related]
27. Mechanism of platelet effects of cardiotoxins from Naja nigricollis crawshawii (spitting cobra) snake venom.
Kini RM; Evans HJ
Thromb Res; 1988 Nov; 52(3):185-95. PubMed ID: 3194895
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity of Venoms and Cytotoxins from Asiatic Cobras (
Chong HP; Tan KY; Liu BS; Sung WC; Tan CH
Toxins (Basel); 2022 May; 14(5):. PubMed ID: 35622581
[TBL] [Abstract][Full Text] [Related]
29. Species difference in modulation of calcium release by Naja naja kaouthia snake venom cardiotoxin in terminal cisternae from human and equine skeletal muscle.
Fletcher JE; Tripolitis L; Beech J
Toxicon; 1993 Jan; 31(1):43-51. PubMed ID: 8446962
[TBL] [Abstract][Full Text] [Related]
30. Factors influencing the hemolysis of human erythrocytes by cardiotoxins from Naja naja kaouthia and Naja naja atra venoms and a phospholipase A2 with cardiotoxin-like activities from Bungarus fasciatus venom.
Jiang MS; Fletcher JE; Smith LA
Toxicon; 1989; 27(2):247-57. PubMed ID: 2718193
[TBL] [Abstract][Full Text] [Related]
31. Biochemical and pharmacological properties of cardiotoxins isolated from cobra venom.
Hider RC; Khader F
Toxicon; 1982; 20(1):175-9. PubMed ID: 7080031
[TBL] [Abstract][Full Text] [Related]
32. Effects on muscle of a toxin from Indian cobra (Naja naja naja) venom.
Charles AK; Gangal SV; Deshpande SS; Joshi AP
Toxicon; 1982; 20(6):1019-35. PubMed ID: 7164106
[TBL] [Abstract][Full Text] [Related]
33. Dual effect of cobra cardiotoxin on vascular smooth muscle and endothelium.
Ho KH; Kwan CY; Huang SJ; Bourreau JP
Zhongguo Yao Li Xue Bao; 1998 May; 19(3):197-202. PubMed ID: 10375725
[TBL] [Abstract][Full Text] [Related]
34. Validation of a cell-based assay to differentiate between the cytotoxic effects of elapid snake venoms.
Kalam Y; Isbister GK; Mirtschin P; Hodgson WC; Konstantakopoulos N
J Pharmacol Toxicol Methods; 2011; 63(2):137-42. PubMed ID: 20849965
[TBL] [Abstract][Full Text] [Related]
35. Factors in snake venoms that increase capillary permeability.
Miller RA; Tu AT
J Pharm Pharmacol; 1989 Nov; 41(11):792-4. PubMed ID: 2576052
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory Activity of Caspian Cobra (Naja naja oxiana) Snake Venom on the Serum Level of Interleukin-27 and Histopathological Changes in Myelin Oligodendrocyte Glycoprotein-experimental Autoimmune Encephalomyelitisinduced Mice.
Mohammadnejad L; Zare Mirakabadi A; Oryan S; Jelodar Dezfouli S
Arch Razi Inst; 2021 Jan; 75(4):491-500. PubMed ID: 33403844
[TBL] [Abstract][Full Text] [Related]
37. Development of a human scFv antibody targeting the lethal Iranian cobra (Naja oxiana) snake venom.
Kazemi-Lomedasht F; Yamabhai M; Sabatier JM; Behdani M; Zareinejad MR; Shahbazzadeh D
Toxicon; 2019 Dec; 171():78-85. PubMed ID: 31622638
[TBL] [Abstract][Full Text] [Related]
38. An immunodetection assay developed using cobra cytotoxin-specific antibodies: Potential diagnostics for cobra envenoming.
Ong HL; Tan CH; Lee LP; Khor SM; Tan KY
Toxicon; 2022 Sep; 216():157-168. PubMed ID: 35868411
[TBL] [Abstract][Full Text] [Related]
39. On the interaction of cobra venom protein cardiotoxins with erythrocytes.
Zusman N; Miklas TM; Graves T; Dambach GE; Hudson RA
Biochem Biophys Res Commun; 1984 Oct; 124(2):629-36. PubMed ID: 6333874
[TBL] [Abstract][Full Text] [Related]
40. Proteome Analysis of Toxic Fractions of Iranian Cobra (Naja naja Oxiana) Snake Venom Using Two-Dimensional Electrophoresis and Mass Spectrometry.
Samianifard M; Nazari A; Tahoori F; Mohamadpour Dounighi N
Arch Razi Inst; 2021 Mar; 76(1):127-138. PubMed ID: 33818965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
